Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
KYTX
Kyverna Therapeutics, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$6.80
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$420.54M
RECENT INSIDER TRADES
2026-05-29
· Cohen Fred E
(Director)
· OTHER
2026-05-29
· CLARK IAN T
(Director)
· OTHER
2026-03-17
· GRASSO MARC
(Chief Financial Officer)
· OTHER
2026-03-17
· Biddle Warner Weston
(Chief Executive Officer)
· OTHER
2026-03-17
· GEHCHAN NAJI
(See Remarks)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
130
Shares held
48,739,624
Value
$395.31M
Percent of shares outstanding
78.81%
As of quarter end
2026-06-30
RECENT NEWS
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
Kyverna Therapeutics reports positive topline data for SPS and GMG trials
Kyverna reports one-year miv-cel data in stiff person syndrome and myasthenia gravis
Kyverna Therapeutics presents at Morgan Stanley Global Healthcare Conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Kyverna Therapeutics, Inc. (KYTX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit